SCHEMBL7779248

SCHEMBL7779248

Cc1ccccc1-c1c(-c2ccc(S(N)(=O)=O)cc2)nn(CCCO)c1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.53
PTGS1 P23219 5/20 0.53
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
LDHA P00338 1/20 0.40
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
PTGES O14684 2/20 0.38
PDPK1 O15530 3/20 0.37
HDAC3 O15379 1/20 0.37
PDE5A O76074 1/20 0.37
ABCB11 O95342 1/20 0.37
MT-CO2 P00403 1/20 0.37
LMNA P02545 1/20 0.37
CA3 P07451 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX5 P09917 1/20 0.37
ADORA3 P0DMS8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780862 0.91 PTGS2 (0.56) PTGS2PTGS1SCN5ASCN9A
SCHEMBL7780842 0.87 PTGS2 (0.70) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777909 0.87 PTGS2 (0.61) PTGS2PTGS1CA1CA2CA9
SCHEMBL7777719 0.86 PTGS2 (0.53) PTGS2PTGS1CA12CA1CA2
SCHEMBL8629101 0.86 F10 (0.39) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777978 0.86 PTGS2 (0.62) PTGS2PTGS1CA12CA1CA2
SCHEMBL7773308 0.85 PTGS2 (0.54) PTGS2PTGS1CA12CA1CA2
SCHEMBL7778121 0.84 PTGS2 (0.55) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777890 0.84 PTGS2 (0.57) PTGS2PTGS1CA12CA1CA2
SCHEMBL7778278 0.84 PTGS2 (0.54) PTGS2PTGS1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed